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Mitogen-activated protein kinases (MAPKs) bind and activate their
downstream kinase substrates, MAPK-activated protein kinases
(MAPKAPKs). Notably, extracellular signal regulated kinase 2
(ERK2) phosphorylates ribosomal S6 kinase 1 (RSK1), which
promotes cellular growth. Here, we determined the crystal structure
of an RSK1 construct in complex with its activator kinase. The
structure captures the kinase–kinase complex in a precatalytic state
where the activation loop of the downstream kinase (RSK1) faces
the enzyme’s (ERK2) catalytic site. Molecular dynamics simulation
was used to show how this heterodimer could shift into a signal-
ing-competent state. This structural analysis combined with bio-
chemical and cellular studies on MAPK→MAPKAPK signaling
showed that the interaction between the MAPK binding linear
motif (residing in a disordered kinase domain extension) and the
ERK2 “docking” groove plays the major role in making an en-
counter complex. This interaction holds kinase domains proximal
as they “readjust,” whereas generic kinase domain surface con-
tacts bring them into a catalytically competent state.
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Protein kinase activity is controlled by phosphorylation at itsactivation loop by upstream kinases (1, 2). Therefore, a cat-
alytically competent kinase–kinase pair must involve surface
contacts around the catalytic center of the upstream kinase binding
to the activation loop of the downstream kinase. Because of the
transient and presumably highly dynamic nature of these enzyme–
substrate interactions, little is known about the structural assembly
of cognate kinase–kinase pairs. For example, the pivotal role of
mitogen-activated protein kinase (MAPK)→MAPK-activated pro-
tein kinase (MAPKAPK) signaling events propagating mitogenic
and stress signals is well established, but it is structurally not known
how a catalytically competent MAPK–MAPKAPK enzyme–substrate
complex forms.
Extracellular signals or mitogen stimulation activate the ex-
tracellular signal regulated kinase (ERK) pathway, which com-
prises a hierarchically organized kinase cascade (3, 4). ERK2
becomes phosphorylated by upstream MKK1/2 kinases on a
threonine (Thr185) and a tyrosine (Tyr187) residue located in
its activation loop (5). In turn, activated ERK1/2 activates ri-
bosomal S6 kinase 1 (RSK1) by sequential phosphorylation
events where double-phosphorylated ERK1/2 (ppERK1/2) first
phosphorylates the C-terminal RSK1 kinase domain at its acti-
vation loop (on Thr573). This is required for the activation of the
N-terminal AGC kinase-type domain that will in turn become
capable of phosphorylating cell growth promoting substrates (6).
Other MAPKAPKs such as MAPKAPK2 (MK2) or MAP ki-
nase-interacting serine/threonine-protein kinase 1 (MNK1) have
only one kinase domain that directly phosphorylates downstream
substrates. The three proteins are evolutionarily related, acti-
vated by MAPKs similarly, but they play markedly different
physiological roles (7).
In addition to the transient interactions forming between
enzyme–substrate kinase domain pairs, efficient phosphorylation
of all 11 mammalian MAPKAPKs by MAPKs (e.g., ERK1/2 and
p38 kinases) requires an intact ∼20- to 30-amino-acid-long ex-
tension following the C-terminal kinase domain (8–10). This
region harbors a MAPK binding consensus sequence referred to
as a linear motif (LM) (11). MAPKAPKs all contain a domain
related to the kinase domain of calcium/calmodulin-dependent
kinases (CAMKs), which is phosphorylated in its activation loop
by activated MAPKs. This is the first step in MAPKAPK activa-
tion (12, 13). Different MAPKAPKs have diverse sets of sub-
strates but the first step of MAPK→MAPKAPK activation may
share a common mechanism.
In the present study, we determined the crystal structure of
unphosphorylated ERK2 in complex with an RSK1 construct
composed of the C-terminal kinase domain and the linear motif
(hereafter referred to as RSK1). The complex is in a precatalytic
quaternary arrangement where the activation loop of the down-
stream kinase (RSK1) faces the enzyme’s (ERK2) catalytic site.
Results
Crystal Structure of ERK2–RSK1 Captures a MAPK–MAPKAPK Complex
in a Precatalytic State. To structurally elucidate protein–protein
interactions involved in the first step of RSK1 activation, we
determined the crystal structure of unphosphorylated ERK2
bound to RSK1 at 2.15-Å resolution (Rfree = 20.8%; SI Appendix,
Table S1). This complex captured the quaternary structure of
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a MAPK–kinase substrate pair in which the activation loop of
the downstream kinase is positioned next to the catalytic site
of its activator kinase (Fig. 1A). The face-to-face stoichiometric
complex displays a bipartite protein–protein interface with a
buried surface area of ∼1,500 Å2. The RSK1 linear motif region
forms several hydrogen bonds, salt bridges, and side-chain–
specific van der Waals interactions in the MAPK docking groove
(interface 1, IF1) (Fig. 1B). This part of the new protein–protein
complex shows an excellent agreement to the crystal structure of
ERK2 bound to the chemically synthesized RSK1 linear motif
peptide (11). The second interface (interface 2, IF2) forms be-
tween the two kinase domains and it makes up half of the total
interaction surface. IF2 is dominated by van der Waals inter-
actions and it forms between generic kinase features that are
highly conserved across different kinase families (e.g., Ala-Pro-
Glu, APE motif, the conserved segment of the kinase activation
loop or the P loop involved in ATP cofactor binding) (Fig. 1B).
In contrast, IF1 involves the so-called MAPK docking groove,
which is a protein surface that shows topographical diversity
even between closely related MAPK family members (e.g.,
ERK2, p38α) (11).
To test whether the observed face-to-face arrangement of the
complex plays a role in RSK1 activation, we analyzed the impact
of binding surface disrupting mutations: (i) RSK1 was mutated
in a central linear motif position (the leucine in φA was changed
to glutamate, L714E) or (ii) the linker connecting the linear
motif and the kinase domain was shortened by 2, 4, and 6 resi-
dues (RSK1_ΔL2,4,6). RSK1 activation by preactivated ERK2
was monitored in in vitro kinase assays (Fig. 2A). Whereas
phosphorylation of RSK1_ΔL2 and RSK1_ΔL4 was only slightly
affected, the initial rate of Thr573 phosphorylation was greatly
decreased with RSK1(L714E) and RSK1_ΔL6 compared with
the wild-type substrate (SI Appendix, Fig. S1A). Differences were
not due to impaired structural integrity of RSK1 constructs as
mutants and wild-type displayed identical circular dichroism
spectra (SI Appendix, Fig. S1B). The reduced rate of RSK1(714E)
activation is likely due to its impaired capacity to bind to ERK2 as
their binding affinity is greatly reduced (>50 μM) (SI Appendix, Fig.
S1C). In contrast, RSK1_ΔL6 binds ERK2 with similar affinity
compared with wild type (Kd ∼ 0.2 μM), but it is a suboptimal
substrate because its reduced linker length presumably limits for-
mation of contacts in the face-to-face ERK2–RSK1 heterodimer
at IF2.
Next, phosphorylation of RSK1 mutants was examined in
a cell-based assay to examine the physiological relevance of the
crystallographic complex. HEK293 cells were transiently trans-
fected with RSK1 mutant constructs or with wild type, the ERK
pathway was stimulated by addition of epidermal growth factor
(EGF), and RSK1 phosphorylation following endogenous ERK2
activation was monitored by Western blots using a phospho-
RSK1(Thr573) antibody (Fig. 2B). This cell-based assay showed
that RSK1(L714E) and the RSK1_ΔL6 both had reduced
phosphorylation compared with wild type. Blocking ERK–RSK1
interaction through IF1 appeared to have a more severe impact
in cells [RSK1(L714E)]; nevertheless, EGF stimulation also
caused diminished RSK1_ΔL6 activation. In summary, these
experiments suggest that, despite the fact that ERK2 was
unphosphorylated in the complex, the ERK2–RSK1 crystal
structure captured a physiologically relevant heterodimeric state
that plays a role in ERK2→RSK1 activation.
Molecular Dynamics on ERK2–RSK1 Complexes. The ERK2 catalytic
center and the RSK1 activation loop face each other in the
unphosphorylated ERK2–RSK1 complex. The enzyme’s active
site (Asp149), however, is shielded off from the substrate by the
unphosphorylated ERK2 activation loop (Fig. 1B). Thus, this
crystallographic model likely captures the snapshot of a precatalytic
MAPK–MAPKAPK complex. In contrast, to inactive ERK2, the
activated form has an open active site (5) (Fig. 1B). Therefore, we
used the ERK2–RSK1 binary complex crystal structure as the basis
for generating a phosphoERK2–RSK1 model by superpositioning
double phosphorylated ERK2 (ppERK2) with unphosphorylated
ERK2 within this complex. The complexes were then subjected to
molecular dynamics (MD) simulations.
Unrestrained MD simulation on ppERK2–RSK1 showed
markedly different movements of the activator and substrate ki-
nase domains relative to each other compared with the complex
containing unphosphorylated ERK2. Principal component analysis
of MD results revealed great differences: Diverse domain orien-
tation movements suggested a conformationally divergent ERK2–
RSK1 complex, whereas intramolecular movements were domi-
nating in the ppERK2–RSK1 complex. These latter appeared to
maximize/optimize the interaction surface around ERK2’s cata-
lytic core (SI Appendix and Movie S1). During these simulations
IF1 was highly stable, displaying only small range variations. In
contrast, kinase domain–domain contacts (around IF2) changed
greatly and the buried surface area increased compared with the
starting state (SI Appendix, Fig. S2A). The interaction between
the APE motif of RSK1 and the P loop from ERK2 was stable
for both complexes during the 150-ns-long MD run, and this
prominent contact surface appeared as a pivot point around
which the kinases swiveled to optimize their interaction surface
(SI Appendix and Movies S2 and S3). Although the interaction
surface increased for both complexes, indicating that this can be
optimized compared with what was observed in the crystallographic
complex, contacts became more extensive in the ppERK2–RSK1
complex. This was because RSK1 formed a unique surface with
ppERK2 in addition to contacts formed with unphosphorylated
ERK2. Unique contacts formed between residues of αD and αG
Fig. 1. Structure of the ERK2–RSK1 complex. (A) Crystal structure of the
ERK2 (orange)–RSK1 (green) complex. The RSK1 linear motif region binds to
the MAPK docking groove (interface 1, IF1). RSK1 forms a face-to-face an-
tiparallel kinase dimer with the ERK2 kinase domain through IF2 where the
catalytic aspartate (Asp149, shown in red) is located next to the RSK1 acti-
vation loop (shown in red, and Thr573 is shown with a black sphere). The
nucleotide cofactor (AMPPNP) is colored blue. The unstructured part of the
RSK1 loop is shown with a dashed line. Lower shows the complex from
the back where the electron density for the linear motif (LM), αL, and the
intervening linker region (colored in cyan) is shown with sigmaA-weighted
omit map contoured at 1σ. (B) A close view of IF1 and IF2. At IF1, contacts are
highlighted and labeled according to linear motif consensus (11). Black
dashed lines indicate H-bond interactions. At IF2 contacts form between the
APE motif of RSK1 and the P loop of ERK2 (Cα atoms of residues within van
der Waals contacts are shown with spheres). The dephosphorylated activa-
tion loop of ERK2 blocks the RSK1 phosphorylation site (Thr573 in the TP
motif) from accessing the ERK2 active site (Asp149, shown in stick repre-
sentation in red) and substrate binding pocket. The ppERK2–RSK1 complex
was generated by superposing the ppERK2 structure (PDB ID: 2ERK) with
ERK2 from the crystallographic complex. The phosphorylated activation loop
of ERK2 (with Tyr187 and Thr185) is shown in purple.
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from the C lobe of ppERK2 and the N lobe of RSK1 (e.g., residues
from the P loop, and from loops connecting β3 and αC or β4 and
β5) (SI Appendix, Fig. S2B).
Next, we validated the importance of contacts suggested by the
ppERK2–RSK1 MD model. Ser452 and Glu623 are located on
the N- and C-terminal RSK1 kinase lobes, on the β3–αC loop
and on αG, respectively (Fig. 3A). Note that Ser452 and Glu623
are located on contact surface patches that were implicated by
MD simulations only and they do not form contacts within the
ERK2–RSK1 crystal structure (SI Appendix, Fig. S3A). These
two residues were mutated to bulky tryptophan amino acids. MD
indicated that the RSK1 APE motif is at the center of kinase
domain contacts in the ERK2–RSK1 heterodimer and this re-
gion was also subjected to amino acid replacements. The impact
of these mutations or their combination were tested in in vitro
kinase assays and in cell-based assays (Fig. 3 B and C and SI
Appendix, Fig. S3 B and C). In line with the results of in vitro
kinase assays, RSK1 mutants got activated less in a cell-based
assay where ERK2 and RSK1 phosphorylation was triggered by
stimulating cells with EGF. To demonstrate that RSK1 mutants
were structurally intact and could bind ERK2 through their
linear motif region, the RSK1(APE/623) construct was subjected
to circular dichroism and ERK2 binding measurements (SI Ap-
pendix, Fig. S3D). This RSK1 mutant, that ppERK2 activated the
least, did not show any difference compared with wild type, in-
dicating that its structure and enzyme binding capacity stayed
intact. Because amino acid replacements had to be made on an
extensive, presumably dynamic and “loose” interface where van
der Waals interactions appeared to dominate, residues were
changed to bulky amino acids such as to tryptophan or arginine
instead of alanines. We argued that some local clashes would
rather impede dynamic complex assembly as opposed to mere
side-chain shortening on an extensive IF2-like surface. In summary,
our experimental results validated ERK2–RSK1 MD models and
show that we correctly identified kinase domain contacts that
govern signaling in a physiologically relevant catalytic complex.
Structural Model of the Catalytic ppERK2–RSK1 Complex. The
ppERK2–RSK1 MD model clearly demonstrated that the criti-
cal RSK1 activation loop region containing Thr573 and Pro574
could flip into the ERK2 substrate binding pocket without per-
turbing the compact quaternary arrangement observed in the
150-ns-long MD simulation (Fig. 4). Because this structural model
was conducive to a signaling competent complex, we attempted to
obtain a structural model for a catalytic ppERK2–RSK1 enzyme–
substrate complex. The catalytic aspartate (Asp149) is ∼30 Å apart
from Thr573 of RSK1 in the ERK2–RSK1 crystal structure
(measured between their Cα atoms), but MD simulations in-
dicated that the RSK1 activation loop is a highly flexible region of
the kinase domain (SI Appendix, Fig. S4A). The distance between
Thr573 (RSK1) and Asp149 (ERK2) indeed decreased in the
course of the 1-μs-long unrestrained MD simulation on ppERK2–
RSK1 (SI Appendix, Fig. S4B). However, the simulation time was
presumably not long enough to capture the catalytic complex
where the RSK1 TP motif binds into the ERK2 substrate pocket
and becomes optimally positioned for phosphotransfer. Similarly
to other so-called proline-directed serine–threonine kinases, the
substrate binding pocket of MAPKs accepts serine or threonine
residues that are followed by a proline (S/TP motifs). Because
proline-directed kinases presumably bind their substrates similarly,
an optimal distance for the two critical ERK2 and RSK1 residues
could be obtained based on a related proline-directed kinase–
substrate complex structure (14). The Thr-Pro motif region of the
RSK1 activation loop was superimposed with the corresponding
residues from the DYRK1A–substrate peptide complex and the
loop conformation was minimized (SI Appendix, Fig. S4B). This
approach gave a feasible “restrained” structural model for the
catalytic ppERK2–RSK1 complex. Moreover, energy calculations
on the starting, the unrestrained, and the restrained models in-
deed indicated that the catalytic interface increasingly contributed
to the total computed interaction energy of the ppERK2–RSK1
complex (SI Appendix, Fig. S4C).
Role of the MAPKAPK APE Motif in Activator Kinase Binding. The
major contact between kinases at IF2 forms between the glycine-
rich P loop of ERK2 and the APE motif of RSK1 in the ERK2–
RSK1 crystal structure. In addition, MD simulations on ppERK2–
RSK1 implicated these generic regions as pivots around which
kinase domain contacts get optimized during ppERK2→RSK1
phosphorylation. In kinases the P loop is involved in ATP binding
and ADP release, whereas the APE motif plays a pivotal role in
protein substrate binding at the P+ side (15). In calcium/cal-
modulin-dependent protein kinases (CAMKs) an inhibitory helix
sterically blocks the binding of substrates by occluding the sub-
strate binding pocket (16). Similarly, the αL helix plays the same
role in the related C-terminal kinase domain of MAPKAPKs (Fig.
5A). In contrast to other known protein kinases, the APE motif
occupies a noncanonical position in all inactive MAPKAPK
structures (for example it is part of the extended αF helix in
known RSK structures), whereas in their active state—after
Fig. 2. Experimental validation of ERK2–RSK1 contacts. (A) RSK1 mutants
display reduced phosphorylation by preactivated ERK2. Phosphorylation rate
of RSK1 was monitored by in vitro kinase assays (SI Appendix, Fig. S1). L714E
has a mutation at IF1, whereas linker length mutants (Δ2–6) affect contacts
at IF2 indirectly. The bar graph shows relative RSK1 phosphorylation, which
was calculated based on initial phosphorylation rates that were normalized
to wild type (WT), and error bars show the SDs from mean value; n = 3
experiments (SI Appendix, Fig. S1A). (B) RSK1 mutants display reduced acti-
vation capacity upon EGF stimulation in HEK293 cells. (Right) Representative
set of three independent experiments where samples were taken at the
indicated time points after EGF treatment of serum-starved HEK293 cells.
Heterologous RSK1 and endogenous ERK activation, the latter as a control
for EGF treatment, were monitored by Western blots with phospho-RSK1
(Thr573) and ppERK2-specific antibodies, respectively. Transiently trans-
fected RSK1 constructs had a FLAG tag, and anti-FLAG Western blotting was
used to demonstrate equal load for different samples and uniform trans-
fection efficiency for different experiments.
Fig. 3. Experimental validation of surface contacts from the ppERK2–RSK1
MD model. (A) MD predicts that Ser452 and Glu623 play a role in the cat-
alytic ppERK2–RSK1 complex. Phosphorylation rate of RSK1 was monitored
by using in vitro kinase assays (SI Appendix, Fig. S3B). (B) The bar graph
shows relative RSK1 phosphorylation, which was calculated based on initial
phosphorylation rates that were normalized to wild type (WT), and error
bars show the SDs from mean value; n = 3 experiments. (APE: RSK1 mutant
with a modified APE motif; 452 or 623: Ser452 or Glu623 were changed to
tryptophans; APE/623: two mutated regions are combined within one RSK1
construct.) (C) Results of RSK1 activation in EGF-stimulated cells. Blots show
a representative set of three independent experiments where samples were
taken at the indicated time points after EGF treatment of serum-starved
HEK293 cells. Heterologous RSK1 and endogenous ERK activation or equal
protein load were analyzed similarly as in Fig. 2 (and control blots for ppERK
and RSK1 level are shown on SI Appendix, Fig. S3C). (For comparison, the
blot for WT is the same as in Fig. 2.)








MAPK-mediated phosphorylation on their activation loop—this
region presumably displaces αL so as to play the same pivotal role
in substrate binding as in all kinases (Fig. 5B) (17).
The APE motif region of αF may undergo a major confor-
mational change that is triggered by phosphorylation of the
MAPKAPK activation loop. These intramolecular rearrange-
ments then create a functional substrate binding pocket on
MAPKAPKs (17, 18). For RSK1, and presumably for other
MAPKAPKs, the APE region is also involved in activator kinase
binding in addition to its canonical role in downstream substrate
binding. Thus, uniquely, the MAPKAPK APE region plays a
dual role. The ERK2 P loop in the complex also has an un-
expected role: In addition to ATP binding, it is involved in sub-
strate kinase binding as it contacts the RSK1 APE motif (Fig. 1B).
Determinants of MAPK→MAPKAPK Signaling Specificity. Bimolec-
ular fluorescence complementation (BiFC)-based cellular assays
showed that the RSK1 linear motif is absolutely necessary to
mediate the binary interaction between ERK2 and its substrate
kinase in the cell (SI Appendix, Fig. S5). In addition, we formerly
showed that linear motif containing peptides from RSK1, MK2,
and MNK1 bind to MAPKs with well-defined selectivity profiles
that match to MAPK→MAPKAPK biological specificity: RSK1
and MK2 linear motif peptides bound their cognate MAPKs with
submicromolar affinities (<0.5 μM), whereas they bound non-
cognate MAPKs weaker (Kd ∼ 10–20 μM) (11). In agreement with
the biological role of MNK1, the linear motif containing peptide
from this protein bound both to ERK2 and p38α with equal
(∼0.5 μM) binding affinity (11). Here, we examined the behavior
of three MAPKAPK peptides in solution using NMR-based sec-
ondary chemical shift (SCS) analysis (SI Appendix, Fig. S6). Var-
iation of SCS values for Hα, Cα, and Cβ resonances along the
peptide chain can reveal secondary structure propensities in
unfolded and partly folded proteins. Although all linear motif
peptides adopt a characteristic binding conformation upon
binding to MAPKs, they were found to be disordered in solution.
This analysis in combination with structure solution of MAPKs
in complex with linear motif containing peptides and MAPK–
MAPKAPK protein–protein complexes suggests that these
MAPKAPK regions undergo disorder-to-order transition upon
binding to the MAPK “docking” groove (11, 19). This is also
supported by the fact that these regions are disordered in mo-
nomeric crystal structures of RSK2 and MK2 (17, 20).
RSK1 and MK2 MAPKAPKs are specifically activated by ERK2
and p38 MAPKs, respectively, whereas MNK1 is activated by both
MAPKs in cells. To address how distinct interfaces contribute to
MAPK–MAPKAPK signaling, we monitored MAPK→MAPKAPK
phosphorylation by in vitro kinase assays using purified proteins
(SI Appendix, Figs. S7 and S8). Changing the unspecific linear
motif in MNK1 into a MAPK specific motif (pepRSK1 or
pepMK2) mildly shifted chimera construct phosphorylation to-
ward corresponding MAPKs as expected (SI Appendix, Fig. S8 A
and B). Similarly, phosphorylation of RSK1 and MK2 chimera
constructs showed agreement to the MAPK binding specificity
profile of their linear motif region (SI Appendix, Fig. S8 C and D).
However, RSK1 and MK2 were phosphorylated not only by their
cognate MAPKs but also by noncognate MAPKs (10). Particu-
larly, ERK2-mediated phosphorylation of MK2 was unexpectedly
high, close to half of what was observed on RSK1 (SI Appendix,
Fig. S8C). Mitogen stimulus involving ERK2 leads to RSK1 but
not to MK2 activation in the cell (10, 13), although MK2 was first
identified as an in vitro ERK2 substrate (21), biochemical speci-
ficity of binary MAPK→MAPKAPK pairs is clearly not sufficient
to explain physiological specificity. In the cell, however, MAPKs
work in the context of other MAPKs. Thus, inactive p38α may
efficiently hinder signaling through the ERK2–MK2 noncognate
kinase pair indirectly. The mechanism is based on interfering with
noncognate recruitment of ERK2 to MK2 because inactive p38α
can bind to the MK2 linear motif region with higher affinity
compared with activated ERK2. When similar in vitro kinase
assays were carried out in the presence of inactive p38α, ERK2-
mediated phosphorylation of MAPKAPKs indeed became specific
and “leakage” between noncognate pairs was abolished (SI Ap-
pendix, Fig. S8E).
These results suggest that linear motif regions have a pivotal
initiator role in complex formation, possibly by tethering the two
kinase domains next to each other. Once an activated MAPK
is recruited, MAPKAPK activation loop phosphorylation pro-
gresses in a nonselective fashion. Correct physiological specificity
was achieved only in the presence of noncognate MAPKs when
illicit MAPK recruitment was efficiently blocked. Thus, additional
surfaces on kinase domains do not greatly influence signaling
specificity. Leakage, however, is influenced by MAPKs from other
signaling pathways, suggesting that higher level contextual factors
also contribute to correct MAPK→MAPKAPK signaling in the
cell (SI Appendix, Fig. S8F).
Discussion
Structural and biochemical characterization of MAPK–MAPKAPK
complexes suggest the first mechanistic model on the structural
assembly of a signaling competent kinase heterodimer (Fig. 6). This
model explains the pivotal role of the linear motif region in
MAPKAPKs and it highlights the role of various catalytic and
noncatalytic kinase surfaces. The short MAPKAPK linear motif
region likely promotes the assembly of an encounter complex in
which the kinase domains are randomly oriented. This complex is
tethered together through a linear motif mediated interaction
Fig. 4. MD simulations on the ppERK2–RSK1 complex. Movements of the
RSK1 activation loop are highlighted (in red). “Starting model” shows a
close-up around the catalytic center; the “unrestrained” model shows the
same region from the MDmodel that displayed the shortest distance between
Thr573(RSK1) and Asp149(ERK2) (SI Appendix, Fig. S4B); and the “restrained
model” was generated by modeling the RSK1 activation loop based on the
DYRK1A–substrate peptide complex (14) (SI Appendix, Fig. S4B).
Fig. 5. Role of the MAPKAPK APE motif and the MAPK P loop in substrate
or activator kinase binding. (A) Inactive, unphosphorylated MAPKAPKs have
a unique APE motif region different from related Ca2+/calmodulin-
dependent protein kinases (CAMK) or from a canonical kinase. (B) Schematic
model of a MAPK→MAPKAPK(CTD) signaling complex. The model depicts
the dual role of the APE motif in activator kinase binding for unphos-
phorylated MAPKAPKs as well as in downstream substrate binding after
MAPKAPK activation loop phosphorylation.
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engaging the MAPK docking groove (IF1). The “encounter com-
plex” provides the possibility of readjustments of kinase domain
orientations for maximizing their contacts around IF2 without dis-
assembly (“readjusting complex”). Complete alignment of kinase
domains in which the substrate kinase’s activation loop binds next
to the upstream kinase’s catalytic site requires that the MAPK
activation loop is double phosphorylated. A precatalytic complex
can only transition into a “signaling complex” (modeled by MD in
this study) if the MAPK had been activated by upstream kinases
formerly. As MAPK activation also involves the MAPK docking
groove where MAPK kinases bind to MAPKs, ERK2 activation
and RSK1 phosphorylation happens independently in distinct
heterodimeric complexes. Acknowledgedly, the crystallographic
ERK2–RSK1 complex is not on the pathway to the Michaelis
complex, and it likely represents a complex that is unproductive in
terms of RSK1 activation as the productive complex has to contain
preactivated ERK2. Despite all this, the new ERK2–RSK1 com-
plex was a good starting point for MD to model the ppERK2–
ERK2 signaling competent (or Michaelis) complex. Although
MAPK cascades are organized by scaffolding proteins that may
align and assemble complexes (22), here we demonstrated that
interactions between a linear motif and a dedicated docking
groove is sufficient to promote the assembly of the catalytic
ERK2→RSK1 binary complex. Interestingly, a similar proximity-
induced catalytic mechanism was formerly suggested to facilitate
efficient phosphorylation of the ERK2 target site in the Ets-1
transcription factor (23, 24).
The MAPK docking groove mediated interface engages the
MAPKAPK linear motif. Despite the fact that this interaction
does not involve direct contacts relevant for the catalytic enzyme–
substrate complex, it is absolutely necessary for MAPK–MAPKAPK
complex formation and signaling. Its pivotal role may be explained
by at least two independent mechanisms: (i) Kinetically, a dis-
ordered interacting region may greatly increase the chance of
forming an energetically favorable encounter complex because
the interaction forms through induced fit. Thus, complex form-
ing collisions require far less precise orientation of the inter-
acting molecules at the first encounter (25, 26). The disorder-
to-order transition at the MAPKAPK linear motif likely has only
a small entropic cost so as to form a high-affinity encounter
complex with its compact MAPK partner. (ii) Tethering of ki-
nase domains via a spatially distinct interface may allow read-
justments between kinase domains without dissociation of the
first MAPK–MAPKAPK encounter complex. Fine tuning involves
generic kinase domain regions that will then lead to a signaling
competent complex; however, these generic contacts are in-
sufficient without additional specific contacts to drive the forma-
tion of a signaling binary complex (SI Appendix, Fig. S5). This
presumes that kinase–kinase domain orientations can vary in
readjusting MAPK–MAPKAPK complexes. This is indeed sup-
ported by unrestrained MD simulations on the ERK2–RSK1
complex. In addition, a p38α–MK2 crystallographic model cap-
tured an unrelated, noncatalytic quaternary arrangement com-
pared with what is described in this study (SI Appendix, Fig. S9)
(19, 27). Direct comparison of available MAPK–MAPKAPK
crystal structures shows that the ERK2–RSK1 complex is the
first structure to our knowledge in which the activation loop of
the MAPKAPK is in the vicinity of the MAPK active site. The
p38α–MK2 structure captures an unproductive heterodimer as
critical enzyme and substrate regions cannot meet as captured in
this crystallographic complex. Moreover, this complex showed that
the role of the catalytically incompetent complex is the stabiliza-
tion of unphosphorylated p38. These are in contrast to the ERK2–
RSK1 crystallographic complex.
Interaction at IF1 are highly MAPK specific, as linear motifs
have their own characteristic MAPK binding specificity. Forma-
tion of contacts at IF2 are likely to be MAPKAPK group specific,
as their APE motif is distinct compared with other known kinases,
and it has a unique role in upstream kinase binding. MAPKAPK
contacts at IF2, however, are less specific within family members
as noncognate MAPK–MAPKAPK pairs formed productive
complexes if their kinase domains were tethered close artificially
(SI Appendix, Fig. S8). Overall, contacts through IF1 and IF2
collectively hold the kinase heterodimer in a precatalytic state and
the topography of the active site is presumably similar in all pro-
line-directed kinases as these phosphorylate similar target motifs.
Most of our knowledge on kinase dimerization and activation
is based on crystal structures of symmetrical homodimers (28).
Based on these structures, activation segment exchange for ex-
ample was suggested to be a common mechanism of kinase
autophosphorylation for a subset of protein kinases (29). Dimeric
contacts usually form between αG helices, which are normally
involved in canonical substrate binding (30–32). Interestingly, this
dimerization mode is also observed in known head-to-head het-
erodimeric complex structures (33, 34). However, the ERK2–
RSK1 complex structure revealed an unusual head-to-tail kinase
dimerization mode (28). It also revealed alternative functions of
well-characterized generic kinase regions, in particular for the P
loop and for the APE motif. In addition to the canonical role of
the APE motif in substrate binding at the P+ side, its involvement
in other protein–protein interactions—such as in upstream acti-
vator kinase binding—is unique to MAPKAPKs. This is due to the
special position and/or the flexible nature of this motif in inactive
MAPKAPKs compared with canonical kinases. Previous structural
studies showed that the P loop can directly participate in kinase
dimerization. Examples include unrelated, catalytically competent
homodimeric structures of the prokaryotic kinase PknB (from
Mycobacterium tuberculosis) and human checkpoint kinase
2 (CHK2) or the heterodimeric structure of RIP3 and MLKL
(31, 34, 35) (SI Appendix, Fig. S10). Because the P loop is directly
involved in ATP binding by coordinating the β- and γ-phosphate
groups for optimal phosphotransfer in all kinases, it may also be
that this glycine-rich loop is an ancient allosteric hotspot in pre-
catalytic kinase–kinase complexes.
In conclusion, MAPK→MAPKAPK signaling provides a great
example of how generic kinase domain regions could combine
with more divergent surface regions in a hierarchical assembly
process. This synergism could be particularly important to achieve
functional diversity within kinase cascades using similarly built and
evolutionarily related enzymatic components. Interestingly, MAPK
activation by MAPK kinases (MAPKK), which are also all evolu-
tionarily related, depends on their linear binding motif regions as
well (36). Thus, regarding the nature of interactions leading to
the formation of a signaling competent kinase–kinase complex,
MAPKK→MAPK and MAPK→MAPKAPK activation may be
mechanistically alike.
Methods
Protein Production for Structural Studies. The cDNA of full-length human ERK2
and the RSK1 [C-terminal kinase domain (CTD)-LM] construct containing the C-
terminal RSK1 region between residues 411 and 735 were cloned into modified
pET expression vectors. All protein constructs were expressed in Escherichia coli
Rosetta (DE3) pLysS (Novagen) cells with standard techniques. Dephosphory-
lated ERK2 with N-terminal cleavable hexahistidine tag was coexpressed with
GST-tagged λ-phage phosphatase. RSK1(CTD-LM) was expressed as N-terminal
GST fusion protein with a C-terminal noncleavable hexahistidine tag.
Affinity-purified ERK2 was cleaved by the tobacco etch virus (TEV) protease
Fig. 6. Model on the structural assembly of the signaling competent
MAPK–MAPKAPK complex. The signaling competent ppERK2–RSK1 complex
forms through hierarchical assembly of unique, group specific, and common
kinase surface contacts. (This scheme is partly speculative but it is consistent
with biochemical and structural data presented in this study.)








and samples were further purified by ion exchange on a Resource Q column
(GE Healthcare). Double affinity purified RSK1 was also cleaved by the TEV
protease and the sample was further purified on a HiTrap Blue-Sepharose
column (GE Healthcare). Purified kinases were mixed in 1:1.2 ratio with ERK2 in
excess and the sample was gel filtrated on a Superdex 75 column (GE Health-
care). Fractions corresponding to the stoichiometric complex were pooled and
the sample was concentrated to 10 mg/mL.
Crystallization, Structure Solution, and Refinement. The stock solution of the
final protein sample was supplementedwith 2mMadenosine 5′-(β,γ-imido)tri-
phosphate (AMPPNP) and 2 mM MgCl2. Crystallization was done in stan-
dard sitting drop vapor-diffusion set-up at 23 °C. The crystallization solution
consisted of 0.1 M Mes pH = 6.25, 15% (vol/vol) PEG4000, 0.125 M (NH4)2SO4
and 2% (wt/vol) benzamidine. Drops with plate-shaped crystals (with an
average size of 0.15 mm × 0.15 mm × 0.02 mm) were supplemented with
10% (vol/vol) glycerol before flash cooling in liquid nitrogen. Data were
collected on the PXIII beam line of the Swiss Light Source (Villigen) at 100 K.
Details on data collection, analysis, and structure determination are given in SI
Appendix, Methods.
MD Simulations. Starting MD models for ERK2–RSK1 and ppERK2–RSK1 were
generated from the ERK2–RSK1 crystallographic complex. The crystal struc-
ture of double-phosphorylated ERK2 (ppERK2; PDB ID: 2ERK) was super-
imposed with ERK2 from the unphosphorylated ERK2–RSK1 crystal structure
(giving the starting model for ppERK2–RSK1). The phosphate groups on
Thr185 and Tyr187 were removed from the ppERK2–RSK1 model (giving the
starting model for the unphosphorylated ERK2–RSK1 complex). In all cal-
culations, the GROMACS ver. 4.5.5 program package (37), the Amber-03 (38)
force field was applied along with neutralizing Na+ counter ions and nu-
merous TIP3P (39) explicit water molecules filling a 5-Å spacing between the
protein parts and the edges of the cubic simulation box. The lengths of
the unrestrained MD runs were 1 μs (ppERK2–RSK1) or 150 ns (ERK2–RSK1).
Further details on MD simulation parameters and processing of MD results
are given in SI Appendix, Methods.
ERK2→RSK1 Activation Assays. For in vitro assays, recombinant-expressed
and purified proteins were used, and RSK1 phosphorylation was monitored
by P32 autoradiography or by phospho-Thr573(RSK1) Western blots. Fur-
ther details on in vitro kinase assays are given in SI Appendix,Methods. For
cell-based assays, RSK1 constructs were subcloned into modified pcDNA
3.1 vectors with N-terminal Venus fluorescent protein and C-terminal FLAG
fusion tags (Invitrogen). HEK293T cells were cultured in 96-well plates as
described in detail in SI Appendix, Methods. Cells were transfected with
0.4 μg RSK1 DNA constructs and were serum starved for 24 h. The media
was removed after 40 h from DNA transfection and 100 μL PBS was added
to wells. ERK pathway stimulation was started by addition of EGF (Sigma,
E9644) in 100 ng/mL concentration to each well and stimulation was ter-
minated at different time points by adding 35 μL of 4× SDS loading buffer
to wells. Cells were lysed and 10 μL of each sample was subjected to SDS/
PAGE. Western blots for monitoring RSK1 phosphorylation on Thr573
were done using the phospho-p90RSK (Thr573) primary antibody (Cell
Signaling, 9346). The phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) an-
tibody (Cell Signaling, 9101) and an anti-FLAG antibody (Sigma, F1804)
were used to check endogenous ppERK2 and heterologous RSK1 protein
levels, respectively.
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